{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T16:38:53Z","timestamp":1773074333866,"version":"3.50.1"},"reference-count":27,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100004886","name":"Illinois Department of Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR002002"],"award-info":[{"award-number":["KL2TR002002"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Am Coll Clin Pharm"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Less than 25% of individuals with opioid use disorder access medication treatment. Lower income and segregated Black and Hispanic communities often have little to no access to services. In 2021, the Drug Enforcement Administration authorized opioid treatment programs to add mobile units to their licensure, extending treatment to disproportionately affected communities. The objectives of this study were to describe the service outcomes and buprenorphine dispensing of a mobile medical unit that leverages an interprofessional team incorporating clinical pharmacists to provide low\u2010threshold buprenorphine and primary care in Chicago neighborhoods with high opioid overdose rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study was conducted via chart review for all patients seen by the mobile medical unit between July 1, 2022 and June 30, 2024. Variables collected were demographics (i.e., age, race\/ethnicity, gender, and substance use history), amount of buprenorphine dispensed, and reasons that buprenorphine was not dispensed (if applicable). Descriptive statistics were used for analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During the study period, 737 patients were seen for buprenorphine across 2413 visits. The average patient was a 47\u2010year\u2010old Black male using five bags of opioids daily via insufflation for 20\u2009years. Over 90% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009591) of patients reported polysubstance use. Two\u2010thirds of patients (67.0%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009494) were dispensed buprenorphine across 1219 (70.5%) visits, including 697 (57.2%) 7\u2010day, 291 (23.9%) 2\u2010day, and 231 (18.9%) 3\u2010day supplies. Reasons for not directly receiving buprenorphine when it was available to dispense included: longer duration indicated (25.9%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009132), shorter duration indicated (8.5%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200943), patient required different dosing from protocol (10.4%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200953), suspected diversion (6.7%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200934), patient taking or interested in methadone (2.8%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200914), or other (11.0%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200956).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Mobile medical services with an interprofessional low\u2010threshold approach and direct buprenorphine dispensing offer a unique opportunity to involve clinical pharmacists in life\u2010saving treatment and recovery support for communities with limited buprenorphine access.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jac5.70170","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:26:08Z","timestamp":1768292768000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Expanding Access to Opioid Use Disorder Treatment: Low\u2010Threshold Buprenorphine Dispensing via an Interprofessional Mobile Medical Unit in Chicago"],"prefix":"10.1002","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0964-2574","authenticated-orcid":false,"given":"Abigail T.","family":"Elmes\u2010Patel","sequence":"first","affiliation":[{"name":"Retzky College of Pharmacy University of Illinois Chicago  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0583-308X","authenticated-orcid":false,"given":"Jennie B.","family":"Jarrett","sequence":"additional","affiliation":[{"name":"Retzky College of Pharmacy University of Illinois Chicago  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1080-397X","authenticated-orcid":false,"given":"Antonio D.","family":"Jimenez","sequence":"additional","affiliation":[{"name":"School of Public Health University of Illinois Chicago  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9688-5469","authenticated-orcid":false,"given":"Stockton M.","family":"Mayer","sequence":"additional","affiliation":[{"name":"College of Medicine University of Illinois Chicago  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9509-3219","authenticated-orcid":false,"given":"Sarah E.","family":"Messmer","sequence":"additional","affiliation":[{"name":"College of Medicine University of Illinois Chicago  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"e_1_2_11_2_1","unstructured":"Illinois Department of Public Health \u201cOpioids: Illinois' Other Epidemic \u201dOpioids accessed February 25 2025 https:\/\/dph.illinois.gov\/topics\u2010services\/opioids\/idph\u2010data\u2010dashboard.html."},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2025.3986"},{"key":"e_1_2_11_4_1","unstructured":"Chicago Department of Public Health \u201cChicago Department of Public Health Announces Summer Strategy to Combat Opioid Overdoses \u201d2024 https:\/\/www.chicago.gov\/content\/city\/en\/depts\/cdph\/provdrs\/health_protection_and_response\/news\/2024\/may\/cdph\u2010press\u2010release\u201005\u201015\u20102024.html."},{"key":"e_1_2_11_5_1","unstructured":"Chicago Health Atlas \u201cDrug Overdose Mortality Rate \u201daccessed April 9 2025 https:\/\/chicagohealthatlas.org\/indicators\/VRDO https:\/\/chicagohealthatlas.org\/indicators\/VRDOR."},{"key":"e_1_2_11_6_1","volume-title":"UI Health Mile Square Health Center Community Needs Assessment","author":"Leading Health Futures","year":"2023"},{"key":"e_1_2_11_7_1","unstructured":"Chicago Department of Public Health \u201cOpioid Overdose Surveillance Report 2018 \u201d2018 https:\/\/www.chicago.gov\/content\/dam\/city\/depts\/cdph\/statistics_and_reports\/CDPH\u2010005_OpioidReport_Final.pdf."},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.20622"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.7326\/AITC202201180"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.7326\/M17\u20103107"},{"issue":"4","key":"e_1_2_11_11_1","first-page":"164","article-title":"Medication\u2010Assisted Recovery for Opioid Use Disorder: A Guide | MDedge","volume":"72","author":"Posen A.","year":"2023","journal-title":"Journal of Family Practice"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7325a1"},{"key":"e_1_2_11_13_1","unstructured":"LawAtlas \u201cBuprenorphine Prescribing Requirements and Limitations \u201daccessed November 14 2025 https:\/\/lawatlas.org\/datasets\/buprenorphine\u2010prescribing\u2010requirements\u2010and\u2010limitations."},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.04.021"},{"key":"e_1_2_11_15_1","unstructured":"Illinois Public Health Institute \u201cResponding to Opioid Overdoses and Treating Opioid Use Disorder \u201d2020 https:\/\/www.chicago.gov\/content\/dam\/city\/depts\/cdph\/CDPH\/Healthy%20Chicago\/LA_Full_Report_IPHI.pdf."},{"key":"e_1_2_11_16_1","unstructured":"Illinois Public Health Institute \u201cResponding to Opioid Overdoses and Treating Opioid Use Disorder: A Landscape Analysis of Chicago's West and South Sides \u201d2020."},{"key":"e_1_2_11_17_1","unstructured":"Access Community Health Network \u201cFind an ACCESS Location Near You. Access Community Health Network (ACCESS) \u201daccessed April 28 2025 https:\/\/www.achn.net\/locations\/."},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2023.209160"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1154813"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.18487"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108149"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/29767342251333972"},{"key":"e_1_2_11_23_1","unstructured":"Code of Federal Regulations \u201c42 CFR Part 8\u2014Medication Assisted Treatment for Opioid Use Disorders \u201daccessed June 15 2023 https:\/\/www.ecfr.gov\/current\/title\u201042\/chapter\u2010I\/subchapter\u2010A\/part\u20108."},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2023.209054"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.34540"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/29767342231215178"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109518"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13722\u2010024\u201000484\u20104"}],"container-title":["JACCP:  JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jac5.70170","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jac5.70170","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jac5.70170","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T08:47:43Z","timestamp":1770626863000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/jac5.70170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1002\/jac5.70170"],"URL":"https:\/\/doi.org\/10.1002\/jac5.70170","archive":["Portico"],"relation":{},"ISSN":["2574-9870","2574-9870"],"issn-type":[{"value":"2574-9870","type":"print"},{"value":"2574-9870","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"2025-07-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70170"}}